National Medication Security: Pandemic Lessons

 
PIIS013216250014393-5-1
DOI10.31857/S013216250014393-5
Publication type Article
Status Published
Authors
Occupation: Senior lecturer
Affiliation: Russian State University for the Humanities
Address: Russian Federation, Moscow
Journal nameSotsiologicheskie issledovaniya
EditionIssue 11
Pages140-146
Abstract

The author attempts to analyze primary challenges in the medication supply and to reconsider the key threats to the medication supply in the light of the COVID-19 pandemic challenges. The paper is based on the sectoral statistics, public opinion polls, and expert assessments. The author discusses key factors affecting affordability and availability of medicines, including high import dependency and immature mechanisms of price regulation, re-registration, public procurement and mandatory labeling of medicines. It is stated that the well-established and uninterrupted manufacture of medicines and the availability of Russian raw materials in the domestic pharmaceutical market are the cornerstone of the medication security of Russians.

Keywordspharmaceutical market, provision of medicines, drug safety, accessibility of medicines, pandemic, sanctions, import substitution
Received24.11.2021
Publication date22.12.2021
Number of characters17387
Cite  
100 rub.
When subscribing to an article or issue, the user can download PDF, evaluate the publication or contact the author. Need to register.

Number of purchasers: 0, views: 737

Readers community rating: votes 0

1. Vyalykh N.A. (2020) Social inequality of medical care consumers in Russian society today: social essence and ways of reducing inequality. Vestnik Nizhegorodskogo universiteta im. N.I. Lobachevskogo. Ser.: Social'nye nauki [Bulletin of Lobachevsky State University of Nizhni Novgorod. Social Sciences]. No. 1 (57): 65–73. (In Russ.)

2. Erasova E.A. (2015) Import substitution as a factor of ensure drug safety provision in modern Russia. Uchenye zapiski Sankt-Peterburgskogo imeni V.B. Bobkova filiala Rossijskoj tamozhennoj akademii [Scientific Letters of Russian Customs Academy the St. Petersburg branch named after V. Bobkov]. No. 3 (55): 14–26. (In Russ.)

3. Leshkevich A.A., Yurochkin D.S., Golant Z.M., Narkevich I.A. (2020) Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union. Farmakoekonomika. Sovremennaya Farmakoekonomika i Farmakoepidemiologiya [Farmakoekonomika. Modern Pharmacoeconomic and Pharmacoepidemiology]. No. 13 (2): 193–204. (In Russ.)

4. Meshkovskiy A.P. (2015) On the Problems of Public Drug Supply. Medicinskie tekhnologii. Ocenka i vybor [Medical Technologies. Assessment and Choice]. No. 3 (21): 21–33. (In Russ.)

5. Ovod A.I. (2020) On the development of the pharmaceutical market of the Russian Federation under the conditions of sanction. Azimut nauchnyh issledovanij: ekonomika i upravlenie [Azimuth of Scientific Research: Economics and Administration]. Vol. 9. No. 1 (30): 252–255. (In Russ.)

6. Telnova E.A., Zagoruychenko A.A. (2020) About state regulation in the Russian pharmaceutical market and problems of drug supply. Sovremennaya organizaciya lekarstvennogo obespecheniya [Modern organization of drug supply]. Vol. 7. No. 3: 11–20. (In Russ.)

7. Telnova E.A., Zagoruychenko A.A. (2020) Provision of pharmaceutical market with pharmaceutical substances as a factor of drug safety in the country. Vestnik Roszdravnadzora [Roszdravnadzor Bulletin]. No. 5 (2): 72–78. (In Russ.)

8. Telnova E.A., Plesovskikh A.V. (2019) About the drug provision of the population – from vexed problems to effective solutions. Vestnik Roszdravnadzora [Roszdravnadzor Bulletin]. No. 6: 74–81. (In Russ.)

9. Ulumbekova G.E. (2020) The program of urgent measures in the healthcare sector of the Russian Federation to overcome the systemic crisis. Orgzdrav: novosti, mneniya, obuchenie. Vestnik VSHOUZ [Healthcare Management: News, Views, Education. Bulletin of VSHOUZ]. No. 6 (1): 4–16. (In Russ.)

10. Ulumbekova G.E., Ginoyan A.B., Kalashnikova A.V., Alvianskaya N.V. (2019) Health Care Financing in Russia (2021-2024). Orgzdrav: novosti, mneniya, obuchenie. Vestnik VSHOUZ [Healthcare Management: News, Views, Education. Bulletin of VSHOUZ]. Vol. 5. No. 4: 4–19. (In Russ.)

11. Ulumbekova G.E., Kalashnikova A.V. (2018) Approaches to the formation of the concept of National pharmaceutical policy. Part I. Analysis of the pharmaceutical market in the Russian Federation. Orgzdrav: novosti, mneniya, obuchenie. Vestnik VSHOUZ [Healthcare Management: News, Views, Education. Bulletin of VSHOUZ]. No. 4: 53–75. (In Russ.)

12. Fadeeva E.V. (2019) Availability of Medicines under Conditions of Medicinal Embargo. Sotsiologicheskie issledovaniya [Sociological Studies]. No. 4: 77–85. (In Russ.)

13. Foteeva A.V., Rostova N.B. (2017) Product assortment policy of Russian manufacturers as a component of drug safety of the state. Vestnik Roszdravnadzora [Roszdravnadzor Bulletin]. No. 5: 55–58. (In Russ.)

Система Orphus

Loading...
Up